Table 3. Clinical characteristics of patients exposed to NTM.
| No. | Age/years | Sex | Country | Relevant diagnoses | Organism isolated | Treated? | Steroids? |
| 1 | 21 | M | UK | Cystic fibrosis | M kansasii, M abscessus | Ya | Y |
| 2 | 41 | F | UK | Bronchiectasis | M fortuitum | N | Y |
| 3 | 22 | F | UK | Cystic fibrosis | M chelonae, M abscessus | Ya | Yb |
| 4 | 88 | M | UK | Bronchiectasis | M gordonae | N | N |
| 5 | 28 | M | UK | Cystic fibrosis | M chelonae | Y | N |
| 6 | 59 | F | UK | Bronchiectasis | M chelonae, M xenopi | N | N |
| 7 | 28 | M | UK | Cystic fibrosis | M avium | N | N |
| 8 | 37 | F | UK | Cystic fibrosis | M abscessus, M chelonae | N | N |
| 9 | 72 | M | UK | Bronchiectasis | M chelonae, M gordonae, M fortuitum | N | Yc |
| 10 | 72 | F | UK | Bronchiectasis | M intracellulare | N | N |
| 11 | 57 | F | UK | Bronchiectasis | M avium | Y | N |
| 12 | 75 | M | UK | COPDd | M malmoense | N | Y |
| 13 | 27 | M | UK | Bronchiectasis | M intracellulare | N | N |
| 14 | 76 | M | UK | Bronchiectasis | M avium | Y | N |
| MB10 | 76 | F | US | Bronchiectasis | M avium intracellulare | Y | N |
| MB11 | 65 | F | US | Bronchiectasis | M avium intracellulare | Y | Y |
| MB16 | 64 | F | US | Bronchiectasis | M avium intracellulare | Y | N |
| MB40 | 78 | F | US | Corticosteroid use | M avium intracellulare | N | Y |
| MB41 | 81 | F | US | Bronchiectasis | M avium intracellulare | N | N |
Summary of the clinical characteristics of patients exposed to NTM. M = male, F = female, Y = yes, N = no, Steroids = individual taking steroids currently or within past 6 months. a. low level of adherence to prescribed treatment, b. very recent (2 doses only), c. very low dose (1 mg prednisolone per day), d. chronic obstructive pulmonary disease.